BACKGROUND: Patients with postthrombotic syndrome (PTS) treated with stents are at risk of stent thrombosis (ST). The incidence of ST in the presence and absence of anticoagulation therapy (AT) is unknown. Risk factors are not well understood. PATIENTS AND METHODS: From the prospective Swiss Venous Stent registry, we conducted a subgroup analysis of 136 consecutive patients with PTS. Incidence of ST was estimated from duplex ultrasound or venography, and reported for the time on and off AT. Baseline, procedural, and follow-up data were evaluated to identify factors associated with ST. RESULTS: Median follow-up was 20 (interquartile range [IQR] 9-40) months. AT was stopped in 43 (32%) patients after 12 (IQR 6-14) months. Cumulative inciden...
Objectives We sought to determine the risk of late stent thrombosis (ST) during long-term follow-up ...
ObjectivesThis study sought to study stent thrombosis with the paclitaxel-eluting Taxus stent.Backgr...
BACKGROUND: The long-term incidence of stent thrombosis (ST) and complications after sirolimus-eluti...
BACKGROUND: Patients with postthrombotic syndrome (PTS) treated with stents are at risk of stent thr...
Background: In patients with a venous outflow obstruction following iliofemoral deep vein thrombosis...
Background and Objectives: Findings from randomized controlled trials have showed that there is no d...
International audienceBackground: Post-thrombotic syndrome (PTS) is a frequent complication of deep ...
Venous stenting has become a common treatment option for central deep venous outflow obstructions an...
International audienceBackground: Risk factors for the post-thrombotic syndrome (PTS) remain poorly ...
Abstract Objective Post-thrombotic syndrome (PTS), an important complication of deep venous thrombos...
Background: Stent thrombosis (ST) is an uncommon but serious complication of percutaneous coronary i...
Objectives: To evaluate stent thrombosis (ST) rate after sirolimus-eluting stent (SES) and paclitaxe...
BACKGROUND: The ATTRACT trial (Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Di...
ObjectivesWe sought to determine the risk of late stent thrombosis (ST) during long-term follow-up b...
OBJECTIVES: We sought to determine the risk of late stent thrombosis (ST) during long-term follow-up...
Objectives We sought to determine the risk of late stent thrombosis (ST) during long-term follow-up ...
ObjectivesThis study sought to study stent thrombosis with the paclitaxel-eluting Taxus stent.Backgr...
BACKGROUND: The long-term incidence of stent thrombosis (ST) and complications after sirolimus-eluti...
BACKGROUND: Patients with postthrombotic syndrome (PTS) treated with stents are at risk of stent thr...
Background: In patients with a venous outflow obstruction following iliofemoral deep vein thrombosis...
Background and Objectives: Findings from randomized controlled trials have showed that there is no d...
International audienceBackground: Post-thrombotic syndrome (PTS) is a frequent complication of deep ...
Venous stenting has become a common treatment option for central deep venous outflow obstructions an...
International audienceBackground: Risk factors for the post-thrombotic syndrome (PTS) remain poorly ...
Abstract Objective Post-thrombotic syndrome (PTS), an important complication of deep venous thrombos...
Background: Stent thrombosis (ST) is an uncommon but serious complication of percutaneous coronary i...
Objectives: To evaluate stent thrombosis (ST) rate after sirolimus-eluting stent (SES) and paclitaxe...
BACKGROUND: The ATTRACT trial (Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Di...
ObjectivesWe sought to determine the risk of late stent thrombosis (ST) during long-term follow-up b...
OBJECTIVES: We sought to determine the risk of late stent thrombosis (ST) during long-term follow-up...
Objectives We sought to determine the risk of late stent thrombosis (ST) during long-term follow-up ...
ObjectivesThis study sought to study stent thrombosis with the paclitaxel-eluting Taxus stent.Backgr...
BACKGROUND: The long-term incidence of stent thrombosis (ST) and complications after sirolimus-eluti...